TITLE

Adjunctive treatment with eplerenone reduced 30-day all-cause mortality in acute myocardial infarction

PUB. DATE
January 2006
SOURCE
ACP Journal Club;Jan/Feb2006, Vol. 144 Issue 1, p15
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article focuses on a study conducted to examine the efficacy of eplerenone in reducing 30-day all-cause mortality in acute myocardial infarction (MI). Randomized placebo-controlled trial was conducted on 6632 patients with acute MI complicated by left-ventricular systolic dysfunction and heart failure. Rates of all-cause mortality and death from cardiovascular causes were lower in the eplerenone group than in the placebo group. The groups did not differ for any other outcomes. It was concluded that in patients with acute myocardial infarction complicated by left-ventricular systolic dysfunction and heart failure, adjunctive treatment with eplerenone reduced 30-day all-cause mortality more than placebo.
ACCESSION #
19515999

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics